文献速递胸部肿瘤放疗放疗物理与技术

影像引导后小残差摆位误差对NSCLC根治性放疗心脏剂量与生存的影响

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy.
PubMed 文献 · Radiother Oncol · 2020-04-14

本研究基于475例NSCLC患者,计算含摆位误差的累积剂量,用影像数据挖掘定位与1年生存相关的Δdose区域,并行多因素Cox分析。发现心脏基底部小区域Δdose与1年生存显著相关(p<0.001,HR 1.221/Gy),计划剂量16.2–23.4 Gy的第七八分位组Δdose显著,16.2 Gy阈值在1482例独立队列验证成功。

要点

  • 心脏基底部小区域Δdose与1年生存显著相关,HR 1.221/Gy。
  • Δdose仅在计划剂量16.2–23.4 Gy的第七八分位组显著。
  • 16.2 Gy作为保守阈值在1482例独立队列验证成功。

核心结论

  • 残差摆位误差与生存的关系可由心脏剂量变化解释,心脏基底部存在与生存相关的剂量区域。
  • 心脏基底部损伤剂量阈值介于16.2与23.4 Gy之间,并在独立队列中验证。

研究设计与样本

  • 回顾性队列研究,纳入475例接受根治性放疗的NSCLC患者,计算含摆位误差的累积剂量。
  • 采用影像数据挖掘技术定位Δdose与1年生存相关区域,并行多因素Cox分析及八分位亚组分析。
  • 在来自同一机构的1482例NSCLC独立验证队列中检验剂量阈值。

主要发现

  • 置换检验识别出心脏基底部小区域,其Δdose与1年生存显著相关。
  • 该区域Δdose与常见临床变量无相关性,在多因素Cox回归中显著(p < 0.001,风险比1.221/Gy)。
  • 八分位分析显示Δdose仅在第七八分位组显著,对应计划剂量16.2–23.4 Gy。
  • 以16.2 Gy为保守阈值,验证队列中该区域剂量高于或低于16.2 Gy的患者间见显著差异。

关键数值与推荐

  • 多因素Cox回归:Δdose p < 0.001,风险比1.221/Gy。
  • 八分位分析:Δdose仅在第七八分位组显著,计划剂量16.2–23.4 Gy。
  • 保守剂量阈值取16.2 Gy,并在1482例独立队列中验证。

临床怎么用

  • 根治性放疗NSCLC患者影像引导后应关注心脏基底部残差摆位误差所致剂量变化。
  • 评估心脏基底部剂量时,可将16.2 Gy作为保守参考阈值,但需结合其他区域剂量效应。

局限性

  • 心脏其他区域的剂量效应尚需进一步研究。
  • 本研究为回顾性分析,剂量阈值基于特定分位组分析得出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A recent study of NSCLC patients showed small residual setup errors (shifts) in the direction of the heart following image-guidance were significantly related to overall survival. This study of the dosimetric effects of these residual shifts investigates the hypothesis that observed survival differences were related to a change in heart dose. MATERIALS AND METHODS: Accumulated doses including shifts for each fraction were determined for 475 NSCLC patients. Planning CTs and corresponding dose distributions were deformed to a reference. Image-based data-mining techniques were then applied to the difference between the planned and accumulated dose (Δdose) to determine where Δdose relates to 1-year survival. The significance of Δdose in the identified region was assessed using multivariable Cox analysis. The cohort was then split into octiles, based upon planned dose to the region, and multivariable Cox analysis performed for each sub-cohort to explore the dose response relationship. The identified dose threshold for damage was then tested in an independent validation cohort of 1482 NSCLC patients from the same institution. RESULTS: Permutation testing identified a small region in the heart base where Δdose significantly correlated with 1-year survival. Δdose in this region showed no correlation with common clinical variables, and was significant in multivariable Cox regression (p < 0.001, hazard ratio 1.221/Gy), with increasing change in dose from plan resulting in greater risk of death. Octile analysis revealed Δdose to be significant only in the 7th octile, planning dose 16.2-23.4 Gy, suggesting a steep dose-effect relation for heart damage in this range. Taking 16.2 Gy as a conservative threshold dose, this result was successfully validated, with a significant difference being seen between patients with a region dose above or below 16.2 Gy. CONCLUSIONS: This study suggests the relation between residual set-up errors and survival is explained by changes in cardiac dose, and identifies an area at the heart base where dose is correlated with survival. Our results suggest the dose threshold for cardiac damage is between 16.2 and 23.4 Gy in the base of the heart, which was validated in an independent cohort. However, the dose effect in other regions of the heart should also be investigated.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Johnson-Hart C, Price G, McWilliam A, et al. Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy. Radiother Oncol. 2020. PMID: 32360033. doi:10.1016/j.radonc.2020.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。